Success Story: Rapid EB-1B Approval in 13 Days for an Organic Chemistry Researcher with Direct Premium Processing
Client’s Testimonial:
“Provided excellent service so far, very knowledgeable, well-experienced, helpful team, very quick and proactive in terms of communication, response /feedback with utmost clarity. Quite happy until now. That’s such a pleasant outcome, to see my case approval within 10 days and without any RFE. I express my sincere thanks & gratitude to the entire team Chen immigration. Thank you so much for your invaluable assistance in securing my EB-1B approval. Your expertise in crafting the petition and highlighting my professional achievements was instrumental. I am truly grateful for your hard work and guidance throughout this process.”
On April 7th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for a Scientist in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Scientist
Approval Notice Date: April 7th, 2026
Processing Time: 13 days (Premium Processing Requested)
Case Summary:
Our firm is pleased to share the successful approval of an I-140 EB-1B (Outstanding Professor or Researcher) petition for the client, a researcher in organic chemistry. With Premium Processing requested at the time of filing, USCIS approved the petition in just 13 days, reflecting the strength of the evidence and the clarity of the case presentation.
Accomplishments and Expertise
The client has developed specialized expertise in the structure-guided design, synthesis, and biological evaluation of small-molecule inhibitors. In the petition, we framed the client’s contributions around practical value: showing how careful medicinal-chemistry design choices, enzyme inhibition results, and pharmacokinetic behavior must be evaluated together to understand why promising inhibitors succeed or fail in real biological settings.
We also highlighted that the client’s work is widely recognized. Rather than relying on broad claims of importance, the petition emphasized that the client’s research created usable frameworks and validated reference points that other researchers could rely on when designing new inhibitor series and evaluating lead compound limitations.
In support of the EB-1B petition, we highlighted several objective indicators of influence, while still explaining how an adjudicator would interpret them:
- 10 peer-reviewed journal articles (3 first-authored)
- 181 citations to the client’s published work
We did not present these metrics as automatically sufficient. Instead, we explained that consistent publication in selective venues and sustained citation uptake together support a stronger conclusion: independent researchers found the client’s work reliable enough to cite, compare against, and build upon. That pattern is especially meaningful in medicinal chemistry, where citations often reflect downstream reliance on reported structure-activity relationships, experimentally validated activity trends, and practical guidance on scaffold optimization.
Letters of Recommendation
To further support the petition, we submitted 2 letters of recommendation from experts in the field, including independent perspectives. These letters corroborated the objective evidence and helped translate specialized medicinal-chemistry contributions into clear significance for an adjudicator reviewing the case.
EB-1B Approval and Outlook
This rapid EB-1B approval underscores how a well-organized record can demonstrate outstanding research through a cohesive technical focus, original contributions with practical relevance, and independent reliance reflected in citations. We are honored to have supported the client in this successful petition and look forward to the client’s continued contributions to organic chemistry research that informs future therapeutic innovation.